Attia Enas A S, El Shennawy Dina, Sefin Ashraf
Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Dermatol Res Pract. 2010;2010:503587. doi: 10.1155/2010/503587. Epub 2010 Jun 30.
Background. Interleukin-4 (IL-4), a Th(2) cytokine, can stimulate immunoglobulin E (IgE) transcription. No previous studies evaluated the genetic mechanisms in nonatopic AA patients with elevated serum IgE. Objective. To compare serum IL-4 and total IgE levels between Egyptian nonatopic AA patients and healthy subjects and to investigate a possible relation to HLA-DRB1 alleles. Results. Serum IL-4 and total IgE were measured by ELISA in 40 controls and 54 nonatopic AA patients. Patients' HLA-DRB1 typing by sequence specific oligonucleotide probe technique was compared to normal Egyptian population. We found significantly elevated serum IL-4 and total IgE in AA patients (particularly alopecia universalis, AU, and chronic patients) (P < .01). HLA-DRB111 is a general susceptibility/chronicity allele. DRB113 is a protective allele. DRB101 and DRB107 are linked to chronicity. Localized AA showed decreased DRB103 and DRB107. Extensive forms showed increased DRB108 and decreased DRB104. Elevated IL4 and IgE were observed in patients with DRB107 and DRB111 not DRB1*04. Conclusion. Serum IL-4 and IgE are elevated in nonatopic AA patients, particularly AU and chronic disease. Relevant susceptibility, chronicity, and severity HLADRB1 alleles may have a role in determining type, magnitude, and duration of immune response in AA favouring increased IL4 and IgE.
背景。白细胞介素-4(IL-4)是一种Th2细胞因子,可刺激免疫球蛋白E(IgE)转录。以往尚无研究评估血清IgE升高的非特应性斑秃(AA)患者的遗传机制。目的。比较埃及非特应性AA患者与健康受试者的血清IL-4和总IgE水平,并研究其与HLA-DRB1等位基因的可能关系。结果。采用酶联免疫吸附测定法(ELISA)检测了40名对照者和54名非特应性AA患者的血清IL-4和总IgE。通过序列特异性寡核苷酸探针技术对患者进行HLA-DRB1分型,并与正常埃及人群进行比较。我们发现AA患者(尤其是全秃,AU,以及慢性病患者)的血清IL-4和总IgE显著升高(P <.01)。HLA-DRB111是一种普遍的易感性/慢性病等位基因。DRB113是一种保护性等位基因。DRB101和DRB107与慢性病有关。局限性AA患者的DRB103和DRB107降低。广泛性AA患者的DRB108升高而DRB104降低。在携带DRB107和DRB111而非DRB1*04的患者中观察到IL4和IgE升高。结论。非特应性AA患者的血清IL-4和IgE升高,尤其是AU和慢性病患者。相关的易感性、慢性病和严重程度HLA-DRB1等位基因可能在决定AA免疫反应的类型、强度和持续时间方面发挥作用,有利于IL4和IgE升高。